Minot DeBlois Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
5,371
-79
-1% -$18.4K 1.17% 24
2026
Q1
$1.33M Sell
5,450
-330
-6% -$76.9K 1.21% 20
2025
Q4
$1.2M Sell
5,780
-50
-0.9% -$9.89K 1.07% 30
2025
Q3
$1.08M Sell
5,830
-210
-3% -$36K 0.98% 29
2025
Q2
$923K Sell
6,040
-85
-1% -$13.1K 0.87% 35
2025
Q1
$1.02M Sell
6,125
-284
-4% -$44.4K 1.01% 30
2024
Q4
$927K Buy
+6,409
New +$993K 0.85% 36

Other funds holding JNJ

Minot DeBlois Advisors's JNJ Position: Q2 2026 in Review

Minot DeBlois Advisors reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2026, selling an estimated $18.4K and leaving 5,371 shares worth $1.36M. The position accounts for 1.17% of the portfolio, ranked #24.

Minot DeBlois Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Minot DeBlois Advisors held 5,371 shares of Johnson & Johnson worth $1.36M as of Q2 2026.
  • Minot DeBlois Advisors sold 79 Johnson & Johnson shares in Q2 2026, an estimated $18.4K.
  • Johnson & Johnson made up 1.17% of Minot DeBlois Advisors's portfolio in Q2 2026, its #24 holding.
  • Minot DeBlois Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Minot DeBlois Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.